Literature DB >> 34523288

[Progress in the application of silk fibroin in tissue engineered drug delivery system].

Shengtang Li1,2, Xuewen Shi2, Bo Xu1,2, Ping Zhen2, Songkai Li2.   

Abstract

OBJECTIVE: The properties and characteristics of different types of silk fibroin (SF) drug-loaded sustained-release carriers and their effects on the drug release behavior were reviewed, and the existing problems and development prospects of SF drug-loaded sustained-release carriers in tissue engineering drug delivery system were discussed.
METHODS: The literatures about drug-loaded SF sustained-release carriers in recent years were extensively consulted, and the types of sustained-release carriers, characteristics of drug release, range of applications, advantages and disadvantages, and solutions were summarized and analyzed.
RESULTS: At present, the SF drug-loaded sustained-release carriers are mainly divided into SF microparticles, SF scaffolds, SF membranes, SF hydrogels, SF nanofibers, SF sponges, and so on. These types of SF drug-loaded sustained-release carriers have their own advantages and problems, of which the most prominent problem is the burst release of drugs at the initial stage. While, the initial burst release of drugs can be effectively solved by improving the preparation process and adjusting the material ratio. Different types of drug-loaded sustained-release carriers can be prepared by combining different materials to achieve different application scopes and drug release behaviors under different conditions.
CONCLUSION: SF is a good drug-loaded carrier for tissue engineering, the burst release of drugs at the initial stage can be solved by improving the preparation process and changing the material structure; through the combination of the advantages of various types of SF drug-loaded sustained-release carriers, it is expected to prepare SF drug-loaded sustained-release carriers that meet different clinical needs.

Entities:  

Keywords:  Silk fibroin; sustained drug release; tissue engineering

Mesh:

Substances:

Year:  2021        PMID: 34523288      PMCID: PMC8444144          DOI: 10.7507/1002-1892.202103066

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  32 in total

1.  A heparin-functionalized woven stent graft for endovascular exclusion.

Authors:  Zekun Liu; Zhaozhu Zheng; Kaili Chen; Yi Li; Xiaoqin Wang; Gang Li
Journal:  Colloids Surf B Biointerfaces       Date:  2019-04-14       Impact factor: 5.268

2.  Dual growth factor loaded nonmulberry silk fibroin/carbon nanofiber composite 3D scaffolds for in vitro and in vivo bone regeneration.

Authors:  Deboki Naskar; Ananta K Ghosh; Mahitosh Mandal; Piyali Das; Samit K Nandi; Subhas C Kundu
Journal:  Biomaterials       Date:  2017-05-10       Impact factor: 12.479

3.  Electrospun core-sheath poly(vinyl alcohol)/silk fibroin nanofibers with Rosuvastatin release functionality for enhancing osteogenesis of human adipose-derived stem cells.

Authors:  Mohammad Mehdi Kalani; Jhamak Nourmohammadi; Babak Negahdari; Abdolrasol Rahimi; Scott A Sell
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2019-01-25       Impact factor: 7.328

4.  In vitro and in vivo evaluation of structurally-controlled silk fibroin coatings for orthopedic infection and in-situ osteogenesis.

Authors:  Zhou Wenhao; Teng Zhang; Jianglong Yan; QiYao Li; Panpan Xiong; Yangyang Li; Yan Cheng; Yufeng Zheng
Journal:  Acta Biomater       Date:  2020-09-02       Impact factor: 8.947

5.  In vitro and in vivo evaluation of new PRP antibacterial moisturizing dressings for infectious wound repair.

Authors:  Qianxin Wang; Zhiyong Qian; Bo Liu; Jinglong Liu; Liang Zhang; Juan Xu
Journal:  J Biomater Sci Polym Ed       Date:  2019-03-08       Impact factor: 3.517

6.  Silk fibroin nanoparticles support in vitro sustained antibiotic release and osteogenesis on titanium surface.

Authors:  Shaily Sharma; Subia Bano; Anindya S Ghosh; Mahitosh Mandal; Hae-Won Kim; Tuli Dey; Subhas C Kundu
Journal:  Nanomedicine       Date:  2016-01-07       Impact factor: 5.307

7.  3-D mineralized silk fibroin/polycaprolactone composite scaffold modified with polyglutamate conjugated with BMP-2 peptide for bone tissue engineering.

Authors:  Jingjing Luo; Haitao Zhang; Jiang Zhu; Xiaokang Cui; Junjiu Gao; Xin Wang; Jie Xiong
Journal:  Colloids Surf B Biointerfaces       Date:  2017-12-28       Impact factor: 5.268

Review 8.  Silkworm silk-based materials and devices generated using bio-nanotechnology.

Authors:  Wenwen Huang; Shengjie Ling; Chunmei Li; Fiorenzo G Omenetto; David L Kaplan
Journal:  Chem Soc Rev       Date:  2018-08-28       Impact factor: 54.564

9.  Silk fibroin/cartilage extracellular matrix scaffolds with sequential delivery of TGF-β3 for chondrogenic differentiation of adipose-derived stem cells.

Authors:  Qiang Yang; Bin-Hong Teng; Li-Na Wang; Kun Li; Chen Xu; Xin-Long Ma; Yang Zhang; De-Ling Kong; Lian-Yong Wang; Yan-Hong Zhao
Journal:  Int J Nanomedicine       Date:  2017-09-11

10.  Functionalization of SF/HAP Scaffold with GO-PEI-miRNA inhibitor Complexes to Enhance Bone Regeneration through Activating Transcription Factor 4.

Authors:  Lingling Ou; Yong Lan; Zhiqiang Feng; Longbao Feng; Junjie Yang; Yu Liu; Liming Bian; Jiali Tan; Renfa Lai; Rui Guo
Journal:  Theranostics       Date:  2019-06-09       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.